Mixed Lineage Kinase Domain-Like Pseudokinase (MLKL) Gene Expression in Human Atherosclerosis with and without Type 2 Diabetes Mellitus
Kamal, Amany; Sebak, Samer Ahmed; Sanad, Eman F.;
Abstract
Mixed lineage kinase domain-like pseudokinase (MLKL), one of the main downstream components of the necroptosis or programmed necrosis has recently been demonstrated in advanced atherosclerotic lesions. However, its precise role in the atherosclerosis pathogenesis still requires more elucidation. Our study was set to delineate both the changes in peripheral MLKL gene expression and its influence on disease severity in atherosclerotic patients with and without type 2 diabetes mellitus.
Other data
| Title | Mixed Lineage Kinase Domain-Like Pseudokinase (MLKL) Gene Expression in Human Atherosclerosis with and without Type 2 Diabetes Mellitus | Authors | Kamal, Amany ; Sebak, Samer Ahmed; Sanad, Eman F. | Keywords | Atherosclerosis;Diabetes mellitus;Inflammation;Insulin resistance;Necroptosis | Issue Date | 2021 | Journal | Iranian biomedical journal | Volume | 25 | Issue | 4 | Start page | 265 | End page | 274 | ISSN | 1028-852X 2008-823X |
DOI | 10.52547/ibj.25.4.265 | PubMed ID | 34217157 | Scopus ID | 2-s2.0-85110370566 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.